Modulation of natural killer cell activity by tamoxifen in stage I post-menopausal breast cancer
- 13 May 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (5) , 517-520
- https://doi.org/10.1016/0277-5379(87)90313-0
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Oestrogen as an inhibitor of human NK cell cytolysisFEBS Letters, 1985
- Variation in natural killer activity in peripheral blood during the menstrual cycle.BMJ, 1985
- Tamoxifen as primary treatment of breast cancer in elderly or frail patients: a practical management.BMJ, 1985
- Hormonal modulation of human natural killer cell activity in vitroJournal of Reproductive Immunology, 1985
- In vitro stimulation of human NK activity by an estrogen antagonist (tamoxifen)European Journal of Cancer and Clinical Oncology, 1984
- Effect of Adjuvant Therapy in Primary Breast Cancer in Relation to the Estrogen Receptor LevelPublished by Springer Nature ,1984
- Trimethoprim-induced augmentation of human natural killer activity in vitroImmunopharmacology, 1982
- Factors limiting tumoricidal function of interferon-induced effector systemsCancer Immunology, Immunotherapy, 1981
- Regulation of the immune response by prostaglandinsClinical Immunology and Immunopathology, 1980
- Oestrogen-responsive human breast cancer in long term tissue cultureNature, 1975